跳至主要内容
临床试验/CTRI/2018/06/014394
CTRI/2018/06/014394招募中4 期

Effects of Add-On Treatment with Hydroxychloroquine on Glucose Fluctuations in Indian Type 2 Diabetes Patients Receiving Insulin with other oral therapy.

Dr Arjun Baidya0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
4 期
状态
招募中
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

入选标准

  • patients who are admitted to private hospital for hyperglycemia and during their hospitalization has achieved target glycemic control (7-9%) with Insulin and other oral therapy (Which include metformin, sulphonylureas, glinides, thiazolidine, DPP4i and alpha-glucosidase inhibitors).
  • Treatment with insulin therapy, including once-daily basal insulin, twice-daily premixed insulin therapy, or multiple daily insulin therapy, for at least 2 weeks. Daily insulin dosage <= 60 Units per day.
  • Patients with ideal body weight > 60 kg Compliance
  • Patient able to understand and willing to fully comply with study procedures and restrictions.
  • Patients ready to undergo a follow-up period of 9 days.

排除标准

  • Patients with a history of any retinopathy of any grade including diabetic retinopathy, evidence of an imminent need for retinal laser therapy, uncorrected visual acuity <20/100, abnormal visual fields, difficulty to examine optic disc, or evidence of retinal pigment epithelial abnormalities and patients with history or risk of macular edema.
  • Patients with history of myalgia, aplastic anemia or agranulocytosis, granulocytopenia, psoriasis, porphyria, rash, scaling, scaling eczema, and G6PD deficiency.
  • Patients with significant cardiovascular illness limiting participation of patient in a clinical trial
  • Patients with abnormal renal function (Serum Cr >1.5 mg/dL, BUN > 20 mg/dL).
  • Patients with abnormal liver function (AST and ALT, total bilirubin or alkaline phosphatase > 2.5 times the upper limit of normal values).
  • Patients with dementia or other cognitive impairment prohibiting informed consent.
  • Patients with disease of blood or haematopoetic organs
  • Patients with known history of HIV 1 or HIV 2, Hepatitis B or C Viruses or syphilis infection or malignancy.
  • Pregnant or lactating women
  • Women of childbearing potential not practicing contraception

研究者

发起方
Dr Arjun Baidya

相似试验